CureVac N.V. (FRA:5CV)
4.666
-0.024 (-0.51%)
Aug 14, 2025, 2:21 PM CET
CureVac Revenue
CureVac had revenue of 893.00K EUR in the quarter ending March 31, 2025, a decrease of -92.78%. This brings the company's revenue in the last twelve months to 523.70M, up 787.60% year-over-year. In the year 2024, CureVac had annual revenue of 535.18M with 895.54% growth.
Revenue (ttm)
523.70M
Revenue Growth
+787.60%
P/S Ratio
2.02
Revenue / Employee
579.31K
Employees
983
Market Cap
1.06B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.38B |
Merck KGaA | 21.22B |
Bayer Aktiengesellschaft | 46.17B |
Fresenius SE & Co. KGaA | 22.28B |
Fresenius Medical Care AG | 19.52B |
Sartorius Aktiengesellschaft | 3.47B |
Fielmann Group AG | 2.33B |
Carl Zeiss Meditec AG | 2.18B |
CureVac News
- 6 days ago - GSK, CureVac to receive $740M as COVID vaccine patent dispute with Pfizer, BioNTech settled - Seeking Alpha
- 6 days ago - GSK to be paid up to £370 million after patent row settles in US - Evening Standard
- 6 days ago - CureVac settles patent dispute litigation with Pfizer and BioNTech - Reuters
- 6 days ago - CureVac Resolves Patent Dispute with Pfizer/BioNTech! - Wallstreet:Online
- 6 days ago - EQS-News: CureVac Announces Resolution of Patent Litigation with Pfizer/BioNTech - Wallstreet:Online
- 7 weeks ago - CureVac Announces Voting Results of General Meeting - Accesswire
- 7 weeks ago - CureVac's General Meeting: Key Voting Results Revealed! - Wallstreet:Online
- 7 weeks ago - EQS-News: CureVac Announces Voting Results of General Meeting - Wallstreet:Online